Phase Ib/II open-label, randomized evaluation of efficacy and safety of atezolizumab plus isatuximab versus regorafenib in MORPHEUS-colorectal cancer Meeting Abstract
| Authors: | Desai, J.; Fakih, M.; Pedersen, K. S.; Hong, Y. S.; Segal, N. H.; Allen, S.; Bailey, L.; Lenain, C.; Lu, D.; Sayyed, P. Z.; Schulze, J.; Cecchini, M. |
| Abstract Title: | Phase Ib/II open-label, randomized evaluation of efficacy and safety of atezolizumab plus isatuximab versus regorafenib in MORPHEUS-colorectal cancer |
| Meeting Title: | 2021 Gastrointestinal Cancers Symposium (ASCO GI) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2021 Jan 15-17 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-01-20 |
| Language: | English |
| ACCESSION: | WOS:000636712800136 |
| DOI: | 10.1200/JCO.2021.39.3_suppl.82 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 82 -- Source: Wos |
